GL1X · GenesisL1 explorer

MolNFT v1 · #90098 · protein

Crystal structure of the N-terminal domain of HIV-1 capsid in complex with inhibitor BM4

4E92 · Gag protein: “Crystal structure of the N-terminal domain of HIV-1 capsid in complex with inhibitor BM4”. X-ray diffraction, 2 ligands (0OE, 0OG), 5 pockets (best druggability 0.73). MolNFT v1 #90098 on GenesisL1: 3D structure…

PDB
4E92
Type
protein
Length
280 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Gag protein
UniProt
Q79791
Ligands
0OE, 0OG
Pockets
5 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 59% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BGag proteinprotein14059% helix, 4% strandQ79791

Ligands and binding sites

  • 0OE · 4-{2-[5-(3-chlorophenyl)-1H-pyrazol-4-yl]-1-[3-(1H-imidazol-1-yl)propyl]-1H-benzimidazol-5-yl}benzoic acid · ligand · 2 copies · chains A, B
  • 0OG · 3-{5-[3-ethyl-5-(5-methylfuran-2-yl)-1H-pyrazol-1-yl]-1-[(6-oxo-1,6-dihydropyridin-3-yl)methyl]-1H-benzimidazol-2-yl}-4-hydroxybenzoic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17710.730.78780OE
21230.690.90180OG
31400.680.88220OG
41780.680.8726empty
5540.270.7314empty

Interfaces

1 interface between chains.

  • A–B · 784 Ų buried · 2 hydrogen bonds · protein-protein

Compared structures

  • 4E92 · Crystal Structure of the N-Terminal Domain of HIV-1 Capsid in Complex With Inhibitor BM4 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.